Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.53
-0.09 (-0.48%)
Nov 21, 2024, 3:29 PM EST - Market open
Summit Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -196.68 | -614.93 | -78.78 | -88.6 | -52.7 | -31.77 | Upgrade
|
| Depreciation & Amortization | 1.95 | 2.05 | 2.51 | 2.46 | 2 | 1.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | -0.11 | - | - | - | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 15.01 | 521.39 | 8.47 | - | 0.86 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.13 | -1.92 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 48.72 | 14.11 | 11.95 | 12.8 | 1.77 | 0.92 | Upgrade
|
| Other Operating Activities | 0.36 | 5.02 | 5.65 | 0.82 | -0.66 | 0.78 | Upgrade
|
| Change in Accounts Receivable | - | 0.36 | 0.98 | -1.14 | 0.21 | 5.93 | Upgrade
|
| Change in Accounts Payable | -0.19 | 2.26 | -4.13 | -1.71 | 1.64 | -1.42 | Upgrade
|
| Change in Unearned Revenue | - | - | -7.28 | -0.81 | 5.37 | -2.57 | Upgrade
|
| Change in Other Net Operating Assets | 23.07 | -4.99 | 19.05 | 3.6 | -6.61 | 3.7 | Upgrade
|
| Operating Cash Flow | -112.89 | -76.76 | -41.58 | -72.59 | -48.11 | -22.64 | Upgrade
|
| Capital Expenditures | -0.13 | -0.13 | -0.62 | -0.31 | -0.42 | -0.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.23 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -15.01 | -475.02 | - | - | - | -0.15 | Upgrade
|
| Investment in Securities | -213.12 | -112.86 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -228.26 | -587.77 | -0.62 | -0.31 | -0.42 | -0.37 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 110 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 545 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 545 | 110 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -110 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -24.69 | -25 | - | - | - | Upgrade
|
| Total Debt Repaid | -75.5 | -24.69 | -25 | -110 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -75.5 | -24.69 | 520 | - | - | - | Upgrade
|
| Issuance of Common Stock | 487.21 | 111.82 | 100.4 | 78.09 | 50.6 | 55 | Upgrade
|
| Other Financing Activities | -0.62 | -0.62 | -0.16 | -0.17 | -0.05 | -0.99 | Upgrade
|
| Financing Cash Flow | 411.09 | 86.51 | 620.24 | 77.92 | 50.55 | 54.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.36 | 0.84 | -1.22 | 0.35 | 0.56 | 0.21 | Upgrade
|
| Net Cash Flow | 70.31 | -577.18 | 576.82 | 5.37 | 2.58 | 31.2 | Upgrade
|
| Free Cash Flow | -113.02 | -76.89 | -42.21 | -72.89 | -48.53 | -22.87 | Upgrade
|
| Free Cash Flow Margin | - | - | -5986.67% | -4029.46% | -5643.26% | -2821.27% | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.12 | -0.22 | -0.79 | -0.70 | -0.70 | Upgrade
|
| Cash Interest Paid | 4.44 | 10.65 | 0.43 | 0.09 | - | - | Upgrade
|
| Cash Income Tax Paid | - | 0.05 | - | - | -0.07 | 0.07 | Upgrade
|
| Levered Free Cash Flow | -62.82 | -219.82 | -319.26 | -38.3 | -28.79 | - | Upgrade
|
| Unlevered Free Cash Flow | -55.59 | -209.54 | -316.51 | -38.15 | -28.63 | - | Upgrade
|
| Change in Net Working Capital | -22.37 | -304.91 | 289.79 | -0.77 | -0.73 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.